0001104659-23-039360.txt : 20230330 0001104659-23-039360.hdr.sgml : 20230330 20230330201211 ACCESSION NUMBER: 0001104659-23-039360 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230328 FILED AS OF DATE: 20230330 DATE AS OF CHANGE: 20230330 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MCCANN JOE A. CENTRAL INDEX KEY: 0001868644 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39373 FILM NUMBER: 23782480 MAIL ADDRESS: STREET 1: 4850 WEST 78TH STREET CITY: INDIANAPOLIS STATE: IN ZIP: 46268 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: POINT Biopharma Global Inc. CENTRAL INDEX KEY: 0001811764 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 850800493 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4850 WEST 78TH STREET CITY: INDIANAPOLIS STATE: IN ZIP: 46268 BUSINESS PHONE: (317) 543-9957 MAIL ADDRESS: STREET 1: 4850 WEST 78TH STREET CITY: INDIANAPOLIS STATE: IN ZIP: 46268 FORMER COMPANY: FORMER CONFORMED NAME: Therapeutics Acquisition Corp. DATE OF NAME CHANGE: 20200511 4 1 tm2311087-5_4seq1.xml OWNERSHIP DOCUMENT X0407 4 2023-03-28 0 0001811764 POINT Biopharma Global Inc. PNT 0001868644 MCCANN JOE A. 4850 WEST 78TH STREET INDIANAPOLIS IN 46268 1 1 0 0 Chief Executive Officer 0 Stock Option (Right to Buy) 6.78 2023-03-28 4 A 0 692643 0.00 A 2029-03-28 Common Stock 692643 692643 D The option vests 25% on the first anniversary of the date of grant with the remaining 75% vesting in three equal annual installments thereafter. /s/ William L. Demers, by Power of Attorney for Joe A. McCann 2023-03-30